Disease Info Card

Premenstrual Dysphoric Disorder

Information about Premenstrual Dysphoric Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Premenstrual Dysphoric Disorder

Most recent studies have shown that Premenstrual Dysphoric Disorder shares some biological mechanisms with affective-symptoms, anxiety-disorders, bipolar-disorder, depression-postpartum, depressive-disorder, depressive-symptom, dysphoria, headache, major-depressive-disorder, mental-disorders, mood-disorders, mood-swings, obsessive-compulsive-disorder, pain, panic-disorder, phobic-anxiety-disorder, post-traumatic-stress-disorder, premenstrual-syndrome, sleeplessness, social-phobia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Premenstrual Dysphoric Disorder, and have been seen in publications frequently: Circadian Rhythm, Cognition, Diestrus, Habituation, Lactation, Menarche, Menopause, Menstrual Cycle Phase, Menstruation, Metestrus, Ovulation, Parturition, Pathogenesis, Proestrus, Reflex, Response To Fluoxetine, Response To Stress, Secretion, Serotonin Uptake, Startle Response

Quite a number of genes have been found to play important roles in Premenstrual Dysphoric Disorder, such as AR, CHN1, COMT, COPE, DBT, ELANE, ESR1, FDXR, HPSE, NDUFS7, OPN1SW, PLP1, PNN, POMC, PRB1, PRL, SLC6A4, TNFSF14. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.